- Home
- SYBX vs SMTK Comparison
SYBX vs SMTK Comparison
Compare SYBX & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- SMTK
- Stock Information
- Founded
- SYBX N/A
- SMTK 2009
- Country
- SYBX United States
- SMTK United Kingdom
- Employees
- SYBX N/A
- SMTK N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- SMTK
- Sector
- SYBX Health Care
- SMTK
- Exchange
- SYBX Nasdaq
- SMTK NYSE
- Market Cap
- SYBX 16.5M
- SMTK 13.3M
- IPO Year
- SYBX N/A
- SMTK N/A
- Fundamental
- Price
- SYBX $1.36
- SMTK $2.61
- Analyst Decision
- SYBX Hold
- SMTK
- Analyst Count
- SYBX 1
- SMTK 0
- Target Price
- SYBX N/A
- SMTK N/A
- AVG Volume (30 Days)
- SYBX 19.0K
- SMTK 13.3K
- Earning Date
- SYBX 03-18-2025
- SMTK 03-04-2025
- Dividend Yield
- SYBX N/A
- SMTK N/A
- EPS Growth
- SYBX N/A
- SMTK N/A
- EPS
- SYBX N/A
- SMTK N/A
- Revenue
- SYBX $2,777,000.00
- SMTK $40,000.00
- Revenue This Year
- SYBX N/A
- SMTK N/A
- Revenue Next Year
- SYBX N/A
- SMTK N/A
- P/E Ratio
- SYBX N/A
- SMTK N/A
- Revenue Growth
- SYBX 292.23
- SMTK 471.43
- 52 Week Low
- SYBX $1.22
- SMTK $2.01
- 52 Week High
- SYBX $2.04
- SMTK $13.00
- Technical
- Relative Strength Index (RSI)
- SYBX 45.23
- SMTK N/A
- Support Level
- SYBX $1.31
- SMTK N/A
- Resistance Level
- SYBX $1.40
- SMTK N/A
- Average True Range (ATR)
- SYBX 0.07
- SMTK 0.00
- MACD
- SYBX 0.00
- SMTK 0.00
- Stochastic Oscillator
- SYBX 60.61
- SMTK 0.00
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.